Bristol-Myers treatment of idiopathic pulmonary fibrosis gets orphan status
The FDA granted orphan designation to Bristol-Myers’ treatment of idiopathic pulmonary fibrosis, according to a post to the agency’s website.https://thefly.com/landingPageNews.php?id=2838157
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.